AlphaLife Sciences published AuroraPrime RMA 2026.08.30 focusing on handoffs in regulatory affairs, including finding information in associated documents, working with TFLs in a CSR, reusing approved TFLs for a Lay Summary, and expanding a CMC project.

AlphaLife Sciences, a leader in Agentic AI-driven clinical development, advances automated medical writing and regulatory documentation through its AuroraPrime platform, driving efficiency across therapeutic areas. As Microsoft's Global AI Content Automation Partner for Life Sciences, and with support from Johnson & Johnson Innovation JLABS, Google for Startups, the Nvidia Inception Program, and Veeva's AI Program, AlphaLife Sciences accelerates drug R&D and regulatory submissions, helping to deliver life-saving treatments worldwide.